March 28, 2013
Nippon Zoki Pharmaceutical and AnGes MG announced on March 26 that they have entered an exclusive domestic development and marketing agreement for NF-κB decoy oligo for the treatment of degenerative disc disease and other conditions associated with lower back pain...read more